Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 118   

Articles published

JNJ 107.04 +1.48 (1.40%)
price chart
Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute for ...
BOSTON--(BUSINESS WIRE)--The Joslin Institute for Technology Translation (JITT) today announced that three Johnson & Johnson Diabetes Solutions Companies, LifeScan, Inc., Animas Corporation and Calibra Medical, Inc., have joined JITT as Founding ...
Is Johnson & Johnson's Worst Nightmare Becoming Reality?
Johnson & Johnson (NYSE: JNJ ) has been one of the few top healthcare companies to post strong growth within its pharmaceutical segment this year.
Related articles »  
TMC confirms Johnson & Johnson incubator
Johnson & Johnson has similar incubators in San Diego, San Francisco and Boston. And although Houston has long been known as a medical hub, with nearly $1 billion worth of research at the Texas Medical Center annually, something's been missing.
Johnson & Johnson Opens New J-Labs Incubator in Texas  Genetic Engineering & Biotechnology News
TMCx lands major partner in J&J  Houston Chronicle
Related articles »  
Johnson & Johnson Earnings Preview: Pharma Is Where The Party Is
This year has been eventful for Johnson & Johnson. The company completed the divestiture of Ortho-Clinical Diagnostics to Carlyle Group in Q3 2014 and got the approval for its new blockbuster drug Olysio in Europe in the second quarter.
Related articles »  
The Biggest Threat Facing Johnson & Johnson
Johnson & Johnson (NYSE: JNJ ) is one of the globe's biggest healthcare companies. Its businesses include everything from Band-Aids to catheters, to cancer busting compounds.
Johnson & Johnson's Growth Potential Is Stronger Than You Think (JNJ)  Seeking Alpha (registration)
Related articles »  
5 Things Johnson & Johnson's Management Wants You to Know
Earlier this month, healthcare conglomerate Johnson & Johnson (NYSE: JNJ ) reported its third-quarter earnings results, and it was once again business as usual.
Johnson & Johnson Share price: Healthcare Aristocrat Leads Recovery on ...  iNVEZZ
Related articles »  
Johnson & Johnson Fairly Valued - I Will Bet on It
In this article, let�s consider Johnson & Johnson (JNJ), a $297.71 billion market cap that is the world's largest and most diverse healthcare company.
Related articles »  
Johnson & Johnson Recalls Contaminated Xarelto
Microbial contamination in samples of the blockbuster blood thinner Xarelto - used to prevent blood clots and strokes - caused Johnson & Johnson's Janssen unit to recall 13,500 bottles of the drug this week. The recall comes shortly after several new ...
Related articles »  
J&J sales top forecast, helped by drug for hep C
At the end of September, Johnson & Johnson announced plans to buy Alios BioPharma, a biotech company focused on developing existing therapies for viral diseases.
Why I'm in Johnson & Johnson for the long run  The Globe and Mail
Johnson & Johnson Quarterly Profit Rises on Sale of Unit  Bloomberg
Related articles »  
INDIA PRESS-Johnson & Johnson may buy electrolyte drink ORS-L for 7 bln ...
INDIA PRESS-Johnson & Johnson may buy electrolyte drink ORS-L for 7 bln rupees - Times of India. Wed Oct 29, 2014 11:10pm EDT.